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A synthetic route to enantiopure cis-1,3-
dimethyltetrahydroisoquinolines 9, synthetic precursors of 
naphthylisoquinoline alkaloids, has been developed. The synthesis 
relies on the use of a phenylglycinol-derived lactam, 2, as the 
starting enantiopure scaffold. After stereoselective opening of the  
oxazolidine ring, the C-3 methyl substituent was installed taking 
advantage of the lactam carbonyl group by stereoselective 
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Introduction 
The naphthylisoquinoline alkaloids[1] constitute a remarkable 
group of structurally diverse natural products with an 
unprecedented origin,[2] arising from acetate and malonate units 
rather than aromatic amino acids. Their characteristic substitution 
pattern includes a stereogenic biaryl axis and an unusual methyl 
substituent at the 3-position of the isoquinoline ring. They exhibit a 
broad spectrum of important biological activities, among them 
antimalarial, antileishmanial, antitrypanosomal, antitumor, and 
anti-HIV. Many of these alkaloids incorporate a 6,8-dioxygenated 
1,3-dimethyltetrahydroisoquinoline moiety, in some cases with a 
1,3-cis relative configuration, e.g. ancistrocline, ancistrobrevines A 
and D, korupensamine D, and ancistrotectorine (Figure 1). A few 
naphthalene-devoid 1,3-dimethyltetrahydroisoquinolines also occur 
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Figure 1.  Naphthylisoquinoline alkaloids. 
These alkaloids are usually assembled by the bond formation 
between the naphthalene and tetrahydroisoquinoline rings in the 
key synthetic step, so the development of efficient procedures for 
the stereocontrolled construction of these heterocyclic building 
blocks has received considerable attention. However, all previous 
synthetic approaches to cis-1,3-dimethyltetrahydroisoquinolines 9 
involve the reduction (NaBH4 or H2, Pd/C) of the corresponding 
3,4-dihydro derivatives,[4] usually prepared via a Bischler-
Napieralski cyclization.[4a-d,f,g] 
 
Results and Discussion 
We herein report a practical procedure for the synthesis of 
enantiopure cis-1,3-dimethyltetrahydroisoquinolines. From the 
stereochemical standpoint, the synthesis involves two crucial steps: 
i) the stereoselective preparation of an enantiopure 1-methyl-3-
oxotetrahydroisoquinoline derivative 4 by cyclocondensation of δ-
keto acid 1 with (R)-phenylglycinol,[5] followed by removal of the 
chiral inductor from the resulting tricyclic lactam; and ii) the 
stereoselective introduction of the C-3 methyl substituent taking 




































Scheme 1. Synthetic strategy. 
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In the reaction with 1,5-dicarbonyl derivative 1,[6] (R)-
phenylglycinol acts as a chiral latent form of ammonia, in a process 
that mimics the presumed biosynthetic origin of acetogenin 
isoquinoline alkaloids.[7] The cyclocondensation reaction furnished 
a single tricyclic lactam 2 (Scheme 2), whose absolute 
configuration was unambigously established by X-ray 
crystallographic analysis.[8]  
 
Scheme 2. Preparation of the key 1-methyl-3-oxotetrahydroisoquinoline 
intermediate 4a. 
A tentative explanation of the trans 3-H/10b-Me relative 
configuration is that the initially formed imine is in equilibrium 
with two diastereoisomeric oxazolidines and that the irreversible 
final lactamization occurs faster from the oxazolidine that allows a 
less hindered approach of the ester group to the nitrogen, as 
depicted in Scheme 3.  
 
Scheme 3. Lactamization step. 
The reductive opening of the oxazolidine ring was performed 
with Red-Al® and also took place in excellent yield with complete 
stereoselectivity (retention of configuration)[9] to give bicyclic 
lactam 3. Subsequent treatment with sodium in liquid ammonia 
brought about the cleavage of the exocyclic C-N bond to give the 
key tetrahydroisoquinolone intermediate 4a. A further reduction of 
4a with NaBH4/I2, followed by treatment with Pd/C in MeOH to 
cleave[10] the resulting N-epimeric mixture of amino-borane 
complexes, led to amine 6, which was also prepared by LiAlH4 
reduction of 3 followed by debenzylation of the resulting tertiary 
amine 5.  
 
Scheme 4. Access to enantiopure cis-1,3-dimethyltetrahydroisoquinolines. 
Formal synthesis of the naphthylisoquinoline alkaloids 10[17] and 11.[18]   
The stereoselective introduction of the C-3 substituent from 
lactam 4a would be accomplished by hydrogenation of an α-
substituted enamide generated by alkylation of the lactam carbonyl, 
once this was activated as a vinyl triflate.[11] To this end, lactam 4a 
was converted to the N-protected derivatives 4b and 4c (Scheme 
4). The N-acyl substituent would not only act as a protecting group 
but also increase the facial selectivity of the hydrogen uptake. The 
conversion of lactams 4b and 4c into the corresponding vinyl 
triflates 7b and 7c was satisfactorily accomplished with LiHMDS 
and Comins’ triflating reagent.[12] A subsequent alkylation with 
lithium methylcuprate (generated in situ from MeLi and CuI), with 
final quenching with methyl iodide,[11] afforded the methylated 
enamides 8b and 8c in 72% and 81% overall yield, respectively, 
from 4a.  
Finally, catalytic hydrogenation of 8b and 8c under  slightly 
acidic conditions (MeOH, 1.5 equiv of aq HCl, rt, 1 atm) using 
Pd/C as the catalyst took place with complete facial selectivity, 
leading to the respective N-acyl-1,3-cis-
dimethyltetrahydroisoquinolines 9b and 9c in high yield.[13,14] 
Unexpectedly, deprotection of the N-Boc derivative 9b with 
TFA led to a 4:6 epimeric mixture of cis and trans derivatives 9a 
and 1-epi-9a, presumably via a retro-Michael ring opening process 
favored by the methoxy groups, as outlined in Scheme 5.[15]  
 
Scheme 5. Epimerization of 6,8-dioxygenated cis-1,3-disubstituted 
tetrahydroisoquinolines. 
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This problem was overcome by using TMSOTf/2,6-lutidine[16] 
(see Scheme 4), which allowed the N-Boc to be removed in high 
yield, leading to the N-unsubstituted 1,3-cis derivative 9a, an early 
intermediate in a previous synthesis of korupensamine D.[4c,d] On 
the other hand, LiAlH4 reduction of the N-methoxycarbonyl 
derivative 9c led to the N-methyl-cis-tetrahydroisoquinoline 9d. 
Comparison of the sign of the [α] value of 9d with the one 
previously reported for this compound[17] confirmed the 1R,3S 
absolute configuration of our synthetic material. Taking into 
account previous transformations, the synthesis of 
tetahydroisoquinoline 9d constitutes a formal synthesis of O-
methylancistrocline (10)[17] and 5-epi-4’-O-demethyl-
ancistrobertsonine C (11).[18] 
Conclusions 
In summary, we have reported a new strategy for the synthesis of 
enantiopure cis-1,3-dimethyltetrahydroisoquinolines based on the 
use of phenylglycinol-derived tricyclic lactam 2 as the starting 
enantiopure scaffold. After stereoselective opening of the 
oxazolidine ring, the cis-1,3 relative configuration is installed by 
stereoselective hydrogenation of an α−methyl enamide generated 
via a vinyl triflate.  
Given that a variety of enantiopure 1-substituted 3-
oxotetrahydroisoquinolines are easily available by 
cyclocondensation of 2-formylphenylacetic esters with 
phenylglycinol followed by α-amidoalkylation of the resulting 
tricyclic lactams,[19] the methodology here developed opens a 




2,3,6,10b-tetrahydro-5H-oxazolo[2,3-a] isoquinoline (2). A 
solution of compound 1 (1.15 g, 4.81 mmol) and (R)-
phenylglycinol (790 mg, 2.26 mmol) in toluene (40 mL) was 
refluxed for 22 h in a Dean-Stark system. The solvent was removed 
under reduced pressure and the residue was purified by flash 
chromatography under silica (hexane to 7:3 hexane-EtOAc) to 
afford compound 2 (1.06 g, 65%) as a brown solid. [α]22D = – 211.1 
(c = 1.0, CHCl3). 1H NMR (400 MHz, CDCl3, COSY, HETCOR, 
25 ºC): δ = 1.72 (s, 3H, CH3), 3.71 (d, J = 19.0 Hz, 1H, H-6), 3.77 
(d, J = 19.0 Hz, 1H, H-6), 3.81 (s, 3H, CH3O), 3.89 (s, 3H, CH3O), 
4.11 (dd, J = 9.2, 8.0 Hz, 1H, H-2), 4.59 (t, J = 8.4 Hz, 1H, H-2),  
5.33 (t, J = 8.0 Hz, 1H, H-3), 6.30 (d, J = 2.4 Hz, 1H, H-9), 6.45 
(d, J = 2.4 Hz, 1H, H-7), 7.30 (m, 5H, ArH) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 24.9 (CH3), 37.9 (C-6), 55.3 (CH3O), 
56.0 (C-3), 58.2 (CH3O), 70.4 (C-2), 95.1 (C-10b), 98.4 (C-9), 
103.1 (C-7), 118.3 (C-6a), 125.6 (C-m), 127.2 (C-p), 128.6 (C-o), 
132.3 (C-10a), 139.4 (C-i), 157.4 and 160.6 (C-i), 166.2 (CO) ppm. 
IR (KBr): ν = 1514, 1610, 1660, 2256, 2977 cm-1. HRMS (ESI-
TOF) calcd. for C20H21NO4  [M + H]+: 340.1549; found 340.1543. 
 
(1R)-2-[(R)-2-Hydroxy-1-phenylethyl]-6,8-dimethoxy-1-methyl-
3-oxo-1,2,3,4-tetrahydroisoquinoline (3). Red-Al® (2 mL of a 
65% solution in toluene, 6.5 mmol) was slowly added (10 min) to a 
cooled solution (– 78°C) of lactam 2 (220 mg, 0.65 mmol) in 
anhydrous CH2Cl2 (2 mL). The resulting solution was stirred at 
0 °C for 1 h and poured into crushed-ice. The aqueous layer was 
extracted with CH2Cl2, and the combined organic extracts were 
dried, filtered, and concentrated. Flash chromatography (2:8 Et2O-
EtOAc) afforded compound 3 (212 mg, 96%) as a white solid.  
[α]22D = + 13.9 (c = 1.0, CHCl3). 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR, 25 ºC): δ = 1.10 (d, J = 6.4 Hz, 3H, CH3), 3.56 
(d, J = 18.8 Hz, 1H, H-4), 3.73 (s, 3H, CH3O), 3.75 (d, J = 18.8 
Hz, 1H, H-4), 3.77 (s, 3H, CH3O), 4.10 (dd, J = 12.0, 4.4 Hz, 1H, 
CH2OH), 4.28 (dd, J = 12.0, 7.6 Hz, 1H, CH2OH), 4.71 (q, J = 6.4 
Hz, 1H, H-1), 5.15 (dd, J = 7.6, 4.4 Hz, 1H, CHAr), 6.25 (d, J = 
2.0 Hz, 1H, H-7), 6.30 (d, J = 2.0 Hz, 1H, H-5), 7.24-7.34 (m, 5H, 
ArH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 19.9 (CH3), 
38.2 (C-4), 51.0 (C-1), 55.3 (2CH3O), 63.2 (CH2OH), 63.7 
(CHAr), 96.7 (C-7), 102.8 (C-5), 118.5 (C-4a), 127.5 (C-p), 127.8 
(C-o), 128.4 (C-m), 133.4 (C-8a), 136.9 (C-i), 155.1 and 160.0 (C-
i), 170.6 (CO) ppm. IR (KBr): ν = 1513, 1629, 2240, 3400 cm-1. 




tetrahydroisoquinoline (4a). Into a three-necked round-bottomed 
flask equipped with a cold-finger condenser charged with dry ice-
acetone was condensed NH3 (35 mL) at –78 °C. The temperature 
was raised to –33 °C, and a solution of lactam 3 (322 mg, 0.94 
mmol) in THF (3 mL) was added. Then, sodium metal was added 
in small portions until the blue color persisted. The mixture was 
stirred at –33 °C for 1 min. The reaction was quenched by the 
addition of solid NH4Cl until the blue color disappeared. The 
mixture was stirred at room temperature for 4 h, poured into water, 
and extracted with CH2Cl2. The combined organic extracts were 
dried and concentrated to give a clear residue, which was purified 
by chromatography (EtOAc) to afford 4a (201 mg, 97%) as a white 
solid; m. p. 168–171 ºC. [α]22D =  – 31.5 (c = 1.0, CHCl3). 1H NMR 
(400 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ = 1.38 (d, J = 6.9 
Hz, 3H, CH3), 3.45 (d, J = 20.0 Hz, 1H, H-4), 3.65 (d, J = 20.0 Hz, 
1H, H-4), 3.79 (s, 3H, CH3O), 3.81 (s, 3H, CH3O), 4.75-4.82 (m, 
1H, H-1),  6.25 (d, J = 2.2 Hz, 1H, H-7), 6.34 (d, J = 2.2 Hz, 1H, 
H-5), 7.44 (br. s, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): 
δ = 23.4 (CH3), 35.8 (C-4), 47.2 (C-1), 55.2 (CH3O), 55.3 (CH3O), 
96.8 (C-7), 103.1 (C-5), 117.4 (C-4a), 132.9 (C-8a), 156.0 and 
159.8 (C-i), 171.3 (CO) ppm. IR (KBr): ν = 1517, 1668, 2966, 
3217 cm-1. HRMS (ESI-TOF)  calcd. for C12H15NO3 [M + H]+: 
222.1124; found 222.1121. 
 
(R)-2-(tert-Butoxycarbonyl)-6,8-dimethoxy-1-methyl-3-oxo-
1,2,3,4-tetrahydroisoquinoline (4b). n-BuLi (1.6 M in hexane, 
0.28 mL, 0.45 mmol) was added to a solution of lactam 4a (100 
mg, 0.45 mmol) in THF (5 mL) at –78°C. After stirring for 20 min, 
the mixture was transferred via cannula into a cooled (–78°C) 
solution of di-tert-butyldicarbonate (142 mg, 0.68 mmol) in THF 
(2 mL). After stirring for 40 min, a saturated aqueous solution of 
NH4Cl was added. The aqueous layer was extracted with EtOAc. 
The combined organic layers were dried, filtered, and concentrated 
under vacuum. The residue was purified by flash chromatography 
(hexane to 7:3 hexane-EtOAc) to afford compound 4b (112 mg, 
78%) as a white oil. [α]22D = – 55.4 (c = 1.02, CHCl3). 1H NMR 
(400 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ = 1.41 (d, J = 6.6 
Hz, 3H, CH3), 1.56 [s, 9H, C(CH3)3], 3.58 (d, J = 19.5 Hz, 1H, H-
4), 3.79 (s, 3H, CH3O), 3.80 (d, J = 19.5 Hz, 1H, H-4), 3.83 (s, 3H, 
CH3O), 5.64 (q, J = 6.6 Hz, 1H, H-1), 6.25 (d, J = 1.8 Hz, 1H, H-
7), 6.36 (d, J = 1.8 Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 ºC): δ = 20.3 (CH3), 27.9 [C(CH3)3], 39.7 (C-4), 49.3 
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(C-1), 55.3 (2CH3O), 82.9 [C(CH3)3], 96.7 (C-5), 102.6 (C-7), 
117.9 (C-8a), 132.6 (C-4a), 152.0 (C-i), 155.5 (NCO), 160.1 (C-i), 
169.4 (CO) ppm. IR (KBr): ν = 1441, 1502, 1606, 1710, 1776, 
2957 cm-1. HRMS (ESI-TOF) calcd. for C17H23NO5 [M + H]+: 
322.1653; found 322.1649.  
 
(R)-6,8-Dimethoxy-2-(methoxycarbonyl)-1-methyl-3-oxo-
1,2,3,4-tetrahydroisoquinoline (4c). Operating as in the above 
preparation of 4b, from lactam 4a (285 mg, 1.29 mmol) in THF (10 
mL), n-BuLi (1.6 M in hexane, 0.81 mL, 1.29 mmol), and dimethyl 
dicarbonate (210 mg, 1.55 mmol) in THF (7 mL), 
tetrahydroisoquinoline 4c (335 mg, 93%) was obtained as a white 
oil after flash chromatography (7:3 hexane-EtOAc). [α]22D = – 65.4 
(c = 1.03, CHCl3). 1H NMR (400 MHz, CDCl3, COSY, HETCOR, 
25 ºC): δ = 1.42 (d, J = 6.4 Hz, 3H, CH3), 3.62 (d, J = 19.2 Hz, 1H, 
H-4), 3.79 (s, 3H, CH3O), 3.82 (d, J = 19.2 Hz, 1H, H-4), 3.83 (s, 
3H, CH3O), 3.91 (s, 3H, CH3O), 5.73 (q, J = 6.4 Hz, 1H, H-1), 
6.26 (d, J = 1.6 Hz, 1H, H-7), 6.36 (d, J = 1.6 Hz, 1H, H-5) ppm. 
13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 20.3 (CH3), 39.7 (C-4), 
50.5 (C-1), 53.9 (CO2CH3), 55.4 (2CH3O), 96.9 (C-5), 102.7 (C-7), 
117.7 (C-8a), 132.4 (C-4a), 154.4 (NCO), 155.6 and 160.4 (C-i), 
169.6 (CO) ppm. IR (KBr): ν = 1439, 1503, 1606, 1710, 1776, 
2843, 2956 cm-1. HRMS (ESI-TOF) calcd. for C14H17NO5 [M + 
H]+: 280.1177; found 280.1179. 
 
(1R)-6,8-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 
(6). Method A. A solution of iodine (114 mg, 0.45 mmol) in THF 
(2 mL) was slowly added to a cooled (0 ºC) suspension of NaBH4 
(42.7 mg, 1.13 mmol) in anhydrous THF (2.5 mL), and the mixture 
was stirred at this temperature for 5 min (until the solution became 
colorless). Then, a solution of lactam 4a (100 mg, 0.45 mmol) in 
THF (2 mL) was added to the solution (0 ºC). The resulting 
mixture was refluxed for 20 h and cooled to 0ºC. MeOH (5 mL) 
was slowly added, and the stirring was continued at rt for 30 min. 
The solvent was evaporated, and the resulting solid was digested 
with 2 N aqueous KOH (30 min). The resulting suspension was 
extracted with CH2Cl2 and the combined organic extracts were 
dried and concentrated. The resulting residue was dissolved in 
MeOH (2 mL) and stirred for 12 h in the presence of 5% Pd/C (15 
mg, 55% wet). The suspension was filtered, and the filtrate was 
concentrated. Column chromatography (SiO2 previously washed 
with TEA; 95:5 CH2Cl2–MeOH to 90:5:5 CH2Cl2–MeOH–TEA as 
eluent) of the residue afforded an oil (61 mg), which was dissolved 
in CH2Cl2 (8 mL). The solution was washed with saturated aqueous 
NaHCO3, dried, filtered, and evaporated to afford 6 as a yellow oil 
(40 mg, 43%).  
Method B. LiAlH4 (90 mg, 2.4 mmol) was added to a solution of 
lactam 3 (200 mg, 0.6 mmol) in THF (5 mL) at 0°C. The mixture 
was stirred at rt for 2.5 h, cooled to 0°C, and quenched with 
MeOH, water, and 10% aqueous NaOH. The aqueous layer was 
extracted with CH2Cl2, and the combined organic extracts were 
dried and concentrated. Column chromatography (15:85 
hexane/EtOAc) of the residue afforded (1R)-2-[(R)-2-hydroxy-1-
phenylethyl]-6,8-dimethoxy-1-methyl-1,2,3,4-
tetrahydroisoquinoline (5; 110 mg, 56%) as a dark yellow oil. 
[α]22D = –39.2 (c = 0.5, CHCl3). 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR, 25 ºC): δ = 1.36 (d, J = 6.8 Hz, 3H, CH3), 2.58 
(m, 2H, H-4), 2.65 (m, 1H, H-3), 3.10 (m, 1H, H-3), 3.75 (s, 3H, 
CH3O), 3.76 (s, 3H, CH3O), 3.84 (m, 2H, CH2OH), 3.88 (m, 1H, 
CHAr), 4.23 (q, J = 6.4 Hz, 1H, H-1), 6.19 (s, 1H, H-7), 6.27 (s, 
1H, H-5), 7.24-7.34 (m, 5H, ArH) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 ºC): δ = 20.3 (CH3), 27.9 (C-4), 39.7 (C-3), 49.0 (C-1), 
55.1 (CH3O), 55.2 (CH3O), 62.0 (CH2OH), 64.7 (CHAr), 96.4 (C-
5), 103.9 (C-7), 120.9 (C-8a), 127.6 (C-p), 128.2 (C-o), 128.7 (C-
m), 136.5 (C-4a), 138.7 (C-i), 157.3 and 158.5 (C-i) ppm. IR 
(KBr): ν = 3417, 2936 cm-1. HRMS (ESI-TOF) calcd. for 
C20H25NO3 [M + H]+: 328.1907; found: 328.1904. A solution of the 
above amine (110 mg, 0.34 mmol) in EtOH (7.4 mL), 1 N aqueous 
HCl (739 µl), and 5% Pd/C (226 mg, 55% wet) was hydrogenated 
at room temperature and atmospheric pressure for 6 h. The catalyst 
was removed by filtration, the solvent was evaporated, and the 
resulting residue was washed with 1 N aqueous HCl and extracted 
with Et2O. The aqueous phase was basified with saturated aqueous 
NaHCO3 and extracted with CH2Cl2. The combined organic 
extracts were dried and concentrated to give a residue, which was 
chromatographed (SiO2 previously washed with TEA; 95:5 
CH2Cl2–MeOH to 90:5:5 CH2Cl2–MeOH–TEA as eluent) to afford 
6 (66 mg, 94%) as a dark yellow oil. [α]22D = + 10.3 (c = 1.95, 
CHCl3). 1H NMR (300 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ 
= 1.39 (d, J = 6.6 Hz, 3H, CH3), 2.40 (br. s, 1H, NH), 2.66 (dt, J = 
16.5, 3.9 Hz, 1H, H-4), 2.80 (dq, J = 16.5, 10.2, 6.3 Hz, 1H, H-4), 
3.03 (dq, J = 13.2, 5.7, 3.3 Hz, 1H, H-3), 3.21 (dq, J = 13.2, 9.9, 
5.1 Hz, 1H, H-3), 3.77 (s, 3H, CH3O), 3.78 (s, 3H, CH3O), 4.24 (q, 
J = 6.6 Hz, 1H, H-1), 6.22 (d, J = 2.4 Hz, 1H, H-7), 6.29 (d, J = 2.4 
Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 20.8 
(CH3), 29.7 (C-4), 37.9 (C-3), 46.3 (C-1), 55.0 (CH3O), 55.1 
(CH3O), 96.3 (C-5), 104.3 (C-7), 121.7 (C-8a), 136.0 (C-4a), 157.1 
and 158.5 (C-i) ppm. IR (KBr): ν = 2935, 1606 cm-1. HRMS (ESI-
TOF) calcd. for C12H17NO2 [M + H]+: 208.1332; found: 208.1332. 
 
(R)-2-(tert-Butoxycarbonyl)-6,8-dimethoxy-1,3-dimethyl-1,2-
dihydroisoquinoline (8b). LiHMDS (1 M in THF, 0.47 mL, 0.47 
mmol) was slowly added to a solution of lactam 4b (100 mg, 0.31 
mmol) in THF (1 mL) at –78°C. After stirring for 3.5 h, a cooled 
solution (– 78°C) of 2-[N,N-bis(trifluoromethylsulfonyl)amino]-5-
chloropyridine (183 mg, 0.47 mmol) in THF (4 mL) was added via 
cannula, and the mixture was stirred at rt for 16 h. EtOAc (35 mL) 
was added, and the organic layer was washed with water, dried, 
filtered, and concentrated. The resulting residue was 
chromatographed (95:5 hexane-EtOAc) to give (R)-2-(tert-
butoxycarbonyl)-6,8-dimethoxy-1-methyl-3-
(trifluoromethylsulphonyloxy)-1,2-dihydro-isoquinoline (7b; 
130 mg, 94%) as a yellow oil. [α]22D = – 30.3 (c = 1.85, CHCl3). 
1H NMR (400 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ = 1.24 (d, 
J = 7.0 Hz, 3H, CH3), 1.50 [s, 9H, C(CH3)3], 3.80 (s, 3H, CH3O), 
3.82 (s, 3H, CH3O), 5.80 (q, J = 7.0 Hz, 1H, H-1),  6.10 (s, 1H, H-
4), 6.32 (d, J = 2.4 Hz, 1H, H-7), 6.40 (d, J = 2.4 Hz, 1H, H-5) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 18.3 (CH3), 27.9 
[C(CH3)3], 49.7 (C-1), 55.4 (CH3O), 55.5 (CH3O), 83.3 [C(CH3)3], 
98.6 (C-7), 102.1 (C-5), 106.3 (C-4), 117.3 (C-8a), 116.8 (CF3), 
118.4 (q, J = 320.9 Hz, CF3), 129.7 (C-3), 139.1 (C-4a), 151.4 
(NCO), 155.4 and 160.0 (C-i) ppm. IR (KBr): ν = 1459, 1501, 
1607, 1718, 1770, 2976 cm-1. HRMS (ESI-TOF) calcd. for 
C18H22F3NO7 S [M + H]+: 454.1147; found 454.1142. MeLi (1.6 M 
in THF, 47 µl, 0.76 mmol) was added to a suspension of CuI 
(102.8 mg, 0.54 mmol) in THF (2.3 mL) at 0°C. After stirring for 
20 min, the mixture was transferred via cannula into a cooled 
(0°C) solution of the above triflate (70 mg, 0.15 mmol) in THF 
(1.2 mL). The mixture was stirred for 3.5 h, quenched with MeI 
(29 µl, 0.462 mmol), and stirred at rt for 40 min. The solvent was 
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evaporated, the residue was taken up with EtOAc (30 mL) and 
washed with a saturated aqueous solution of NH4Cl. The organic 
layer was dried, filtered, and concentrated. Flash chromatography 
(CH2Cl2) of the residue afforded 8b (48.4 mg, 97%) as a green oil. 
[α]22D = – 331.1 (c = 0.75, CHCl3). 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR, 25 ºC): δ = 1.15 (d, J = 6.8 Hz, 3H, CH3), 1.49 
[s, 9H, C(CH3)3], 2.21 (s, 3H, CCH3), 3.77 (s, 3H, CH3O), 3.79 (s, 
3H, CH3O), 5.68 (q, J = 6.8 Hz, 1H, H-1), 5.83 (s, 1H, H-4), 6.18 
(d, J = 2.4 Hz, 1H, H-7), 6.29 (d, J = 2.4 Hz, 1H, H-5) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25 ºC): δ = 18.3 (CH3), 22.4 (CCH3), 
28.3 [C(CH3)3], 46.8 (C-1), 55.3 (CH3O), 55.4 (CH3O), 80.8 
[C(CH3)3], 96.6 (C-7), 100.1 (C-5), 112.8 (C-4), 116.8 (C-8a), 
132.3 (C-3), 135.4 (C-4a), 152.8 (NCO), 155.2 and 159.5 (C-8) 
ppm. IR (KBr): ν = 1441, 1603, 1640, 1712, 2956 cm-1. HRMS 




dihydroisoquinoline (8c). Operating as in the above preparation of 
7b, from a solution of lactam 4c (300 mg, 1.07 mmol) in THF (3.5 
mL), LiHMDS (1 M in THF, 1.61 mL, 1.61 mmol) and 2-[N,N-
bis(trifluoromethylsulfonyl)amino]-5-chloropyridine in THF (12.5 
mL), (R)-6,8-dimethoxy-2-(methoxycarbonyl)-1-methyl-3-
(trifluoromethylsulfonyloxy)-1,2-dihydroisoquinoline (7c; 375 
mg, 85%) was obtained as a yellow oil after flash chromatography 
(hexane to 85:15 hexane-EtOAc). [α]22D = –157.6 (c = 1.18, 
CHCl3). 1H NMR (400 MHz, CDCl3, COSY, HETCOR, 25 ºC): 
δ = 1.28 (d, J = 6.4 Hz, 3H, CH3), 3.79 (s, 3H, CO2CH3), 3.82 (s, 
6H, 2CH3O), 5.84 (q, J = 6.4 Hz, 1H, H-1), 6.17 (s, 1H, H-4), 6.33 
(d, J = 2.0 Hz, 1H, H-7), 6.41 (d, J = 2.0 Hz, 1H, H-5) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25 ºC): δ = 18.2 (CH3), 50.2 (C-1), 53.6 
(CO2CH3), 55.4 (CH3O), 55.5 (CH3O), 98.8 (C-7), 102.3 (C-5), 
106.9 (C-4), 116.8 (C-8a), 116.9 (CF3), 118.4 (q, J = 320.1 Hz, 
CF3), 129.5 (C-3), 138.4 (C-4a), 153.3 (NCO), 155.3 and 160.0 (C-
8) ppm.  IR (KBr): ν =  1439, 1502, 1612, 1729, 1776, 2850, 2927, 
2956 cm-1. HRMS (ESI-TOF) calcd. for C15H16F3NO7 S [M + H]+: 
412.0677; found 412.0672. Following the procedure reported in the 
preparation of 8b, from the above vinyl triflate (270 mg, 0.66 
mmol) in THF (5 mL), MeLi (1.6 M in THF, 2 mL, 3.2 mmol), CuI 
(438 mg, 2.3 mmol) in THF (10 mL), and MeI (0.12 mL, 1.97 
mmol), compound 8c (180 mg, 99%) was obtained after flash 
chromatography (CH2Cl2). [α]22D = – 327.7 (c = 1.25, CHCl3). 1H 
NMR (400 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ = 1.18 (d, J 
= 6.4 Hz, 3H, CH3), 2.24 (s, 3H, CCH3), 3.75 (s, 3H, CH3O), 3.77 
(s, 3H, CH3O), 3.79 (s, 3H, CH3O), 5.71 (q, J = 6.4 Hz, 1H, H-1), 
5.89 (d, J = 1.2 Hz, 1H, H-4), 6.18 (d, J = 2.4 Hz, 1H, H-7), 6.29 
(d, J = 2.4 Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, CDCl3, 25 
ºC): δ = 18.3 (CH3), 21.8 (CCH3), 47.2 (C-1), 52.7 (CO2CH3), 55.3 
(2CH3O), 96.8 (C-5), 100.4 (C-7), 113.6 (C-4), 116.5 (C-8a), 132.1 
(C-3), 135.1 (C-4a), 154.2 (NCO), 155.1 (C-6), 159.6 (C-8) ppm. 
IR (KBr): ν = 1321, 1442, 1603, 1643, 1713, 2842, 2957 cm-1. 




1,2,3,4-tetrahydro isoquinoline (9b). A solution of 8b (43 mg, 
0.14 mmol) in MeOH (8 mL), 2 N aqueous HCl (105 µl), and 5% 
Pd/C (21 mg, 55% wet) was hydrogenated at rt and atmospheric 
pressure for 6 h. The catalyst was removed by filtration and the 
solvent was evaporated. The resulting residue was diluted in 
CH2Cl2 (15 mL) and the solution was washed with water. The 
organic layer was dried and concentrated to give 9b (44 mg, 97%). 
[α]22D = – 29.9 (c = 0.5, CHCl3).  1H NMR (400 MHz, CDCl3, 
COSY, HETCOR, 25 ºC): δ = 1.33 (d, J = 6.6 Hz, 3H, 
CH2CHCH3), 1.40 (d, J = 6.6 Hz, 3H, CHCH3), 1.48 [s, 9H, 
C(CH3)3], 2.68 (dd, J = 15.9, 6.9 Hz, 1H, H-4), 2.94 (dd, J = 15.9, 
6.9 Hz, 1H, H-4), 3.78 (s, 3H, CH3O), 3.79 (s, 3H, CH3O), 3,.80 
(br. s, 1H, H-3), 5.68 (q, J = 6.6 Hz, 1H, H-1), 6.26 (d, J = 2.4 Hz, 
1H, H-7), 6.32 (d, J = 2.4 Hz, 1H, H-5) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 14.1 (CH2CHCH3), 22.6 (CHCH3), 28.5 
[C(CH3)3], 31.9 (C-4), 35.4 (C-1), 46.8 (C-3), 55.2 (CH3O), 55.3 
(CH3O), 79.2 [C(CH3)3], 96.6 (C-7), 112.8 (C-5), 132.3 (C-8a), 
154.8 (C-4a), 156.3 (NCO), 159.1 (2C-i) ppm. IR (KBr): ν = 1458, 
1609, 1690, 2853, 2925, 2940 cm-1. EM (IQ+): m/z (%) = 306 (11), 
265 (6), 264 (35), 251 (15), 250 (100), 220 (10), 207 (5), 206 (39), 
191(4), 190 (9), 176 (4), 57 (11). HRMS (ESI-TOF) calcd. for 
C18H28NO4 [M + H]+: 322.2013; found 322.1999. 
 
(1R,3S)-6,8-Dimethoxy-2-(methoxycarbonyl)-1,3-dimethyl-
1,2,3,4-tetrahydroisoquinoline (9c). Operating as described in the 
preparation of 9b, from 8c (100 mg, 0.36 mmol) in MeOH (10 
mL), 2 N aqueous HCl (270 µl), 5% of Pd/C (35 mg, 55% wet), 
compound 9c (90 mg, 90%) was obtained. [α]22D = + 13.0 (c = 1.0, 
CHCl3). 1H NMR (400 MHz, CDCl3, COSY, HETCOR, 25 ºC): δ 
= 1.27 (d, J = 6.8 Hz, 3H, CH2CHCH3), 1.34 (d, J = 6.8 Hz, 3H, 
CHCH3), 2.62 (dd, J = 16.0, 6.4 Hz, 1H, H-4), 2.87 (dd, J = 16.0, 
6.8 Hz, 1H, H-4), 3.65 (s, 3H, CO2CH3), 3.71 (s, 3H, CH3O), 3.72 
(s, 3H, CH3O), 4.31 (br. s, 1H, H-3), 5.31 (br. s, 1H, H-1), 6.19 (d, 
J = 2.4 Hz, 1H, H-7), 6.25 (d, J = 2.4 Hz, 1H, H-5) ppm. 13C NMR 
(100.6 MHz, CDCl3, 25 ºC): δ = 20.6 (CHCH3), 21.7 (CH2CHCH3), 
35.2 (C-4), 45.9 (C-1), 46.3 (C-3), 52.4 (CO2CH3), 55.2 (2CH3O), 
96.4 (C-5), 104.1 (C-7), 118.9 (C-8a), 134.7(C-4a), 156.2 (NCO), 
159.2 (2C-i) ppm. HRMS (ESI-TOF) calcd. for C15H21NO4 [M + 
H]+: 280.1543; found 280.1548. 
 
(1R,3S)-6,8-Dimethoxy-1,3-dimethyl-1,2,3,4-
tetrahydroisoquinoline (9a). 2,6-Lutidine (56 mg, 0.48 mmol) 
and TMSOTf (65 µl, 0.36 mmol) were sequentially added to a 
solution of tetrahydroisoquinoline 9b (37 mg, 0.12 mmol) in dry 
CH2Cl2 (308 µl), and the mixture was stirred at 0°C for 1.5 h. The 
reaction was quenched with saturated aqueous NH4Cl, and the 
resulting mixture was extracted with CH2Cl2. The combined 
extracts were washed with saturated aqueous NaHCO3 solution, 
dried, and concentrated to give 9a as yellow oil (27 mg, 98%). 
[α]22D = + 73.0 (c = 0.44, CHCl3). 1H NMR (400 MHz, CDCl3, 
COSY, HETCOR, 25 ºC): δ = 1.23 (d, J = 6.4 Hz, 3H, 
CH2CHCH3), 1.44 (d, J = 6.4 Hz, 3H, CHCH3), 1.70 (br. s, 1H, 
NH), 2.46 (dd, J = 15.2, 11.2 Hz, 1H, H-4), 2.63 (dd, J = 15.6, 2.4 
Hz, 1H, H-4), 2.88 (m, 1H, H-3), 3.78 (s, 6H, 2CH3O), 4.24 (q, J = 
6.4 Hz, 1H, H-1), 6.21 (d, J = 2.0 Hz, 1H, H-7), 6.32 (d, J = 2.4 
Hz, 1H, H-5) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ 22.2 
(CH2CHCH3), 22.7 (CHCH3), 39.7 (C-4), 48.3 (C-1), 49.4 (C-3), 
55.0 (CH3O), 55.2 (CH3O), 96.7 (C-5), 104.4 (C-7), 121.1 (C-8a), 
137.9 (C-4a), 157.9 and 158.5 (C-i) ppm. HRMS (ESI-TOF) calcd. 
for C13H19NO2 [M + H]+: 222.1489; found 222.1489.  
 
(1R,3S)-6,8-Dimethoxy-1,2,3-trimethyl-1,2,3,4-
tetrahydroisoquinoline (9d). LiAlH4 (20 mg, 0.53 mmol) was 
added to a solution of the carbamate 9c (35 mg, 0.13 mmol) in 
THF (1.3 mL) at 0°C. The mixture was stirred at rt for 1 h and then 
Submitted to the European Journal of Organic Chemistry 6
heated to reflux. After 3.5 h, it was cooled to 0 °C and quenched 
with water. After evaporation of the volatile components, the 
residue was diluted with CH2Cl2 and washed with brine. The 
organic extract was dried, filtered, and concentrated to give 9d (26 
mg, 85%) as pale yellow oil. [α]22D = + 123 (c = 1.0, CHCl3) 
[Lit[17] [α]19D = + 120 (c = 1.08, CHCl3)]. 1H NMR (400 MHz, 
CDCl3, COSY, HETCOR, 25 ºC): δ = 1.21 (d, J = 6.4 Hz, 3H, 
CH2CHCH3), 1.36 (d, J = 6.4 Hz, 3H, CHCH3), 2.42 (masked m, 
1H, H-3), 2.45 (s, 3H, NCH3), 2.53 (dd, J = 15.2, 10.4, 0.8 Hz, 1H, 
H-4), 2.68 (ddd, J = 15.2, 2.0 Hz, 1H, H-4), 3.62 (q, J = 6.4 Hz, 
1H, H-1),3.78 (s, 3H, CH3O), 3.79 (s, 3H, CH3O), 6.22 (d, J = 2.4 
Hz, 1H, H-7), 6.31 (d, J = 2.4 Hz, 1H, H-5) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 21.2 (CH3), 22.5 (CH3), 39.1 (CH3), 41.1 
(C-4), 55.0 (CH3O), 55.1 (CH3O), 55.2 (C-1), 56.9 (C-3), 96.5 (C-
5), 103.5 (C-7), 121.2 (C-8a), 137.6 (C-4a), 157.0 and 158.4 (C-i) 




methylethyl]carbamate (12). 1H NMR (CDCl3, 400 MHz, 25 ºC): 
δ = 1.08 (t, J = 7.2 Hz, 3H, CH3CH2); 1.14 (d, J = 6.4 Hz, 3H, 
CHCH3); 2.59 (dd, J = 13.6, 8.4 Hz, 1H, H-2); 2.63 (q, J = 7.2 Hz, 
2H, CH3CH2); 2.92 (dd, J = 13.6, 5.6 Hz, 1H, H-2); 3.65 (s, 3H, 
CO2CH3); 3.77 (s, 3H, CH3O); 3.79 (s, 3H, CH3O); 3.93 (br. a, 1H, 
H-1); 4.63 (br. s, 1H, NH), 6.29 (d, J = 2.4 Hz, 1H, H-6’); 6.35 (d, 
J = 2.4 Hz, 1H, H-4’) ppm. 13C NMR (CDCl3, 100.6 MHz, 25 ºC): 
δ = 14.6 (CH3CH2); 18.8 (CH3CH2); 20.4 (CHCH3); 40.1 (C-2); 
48.0 (C-1); 51.8 (CO2CH3); 55.2 (CH3O); 55.3 (CH3O); 96.8 (C-
4’); 106.3 (C-6’); 124.0 (C-2’); 137.3 (C-1’); 156.3 (NHCO); 158.0 
(C-3’); 158.6 (C-5’). EM (IQ+) m/z (%): 283 (14), 282 (96), 280 
(4), 253 (1), 250 (6). 
Supporting Information (see footnote on the first page of this article): 
Copies of the 1H and 13C NMR spectra of compounds 2-9 and 12, and X-ray 
crystallographic data for compound 2.  
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